GlassScriptPhysician profile
Sarah Yoon
NPI 1669808465
$6,963.32
in general payments reported to CMS, 2019-2025
42 companies · $2,103 in 2025
The $2,103 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,026 · 2022: $732 · 2023: $1,154 · 2024: $1,947 · 2025: $2,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,204.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,498.94 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,091.10 | 2021-2025 | |
| Lilly USA, LLC | $593.40 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $366.95 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.25 | 2021-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $293.56 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $251.55 | 2021-2024 | Eliquis, Camzyos |
| Amgen INC. | $238.35 | 2021-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $210.94 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Lundbeck LLC | $205.36 | 2024-2025 | Rexulti |
| Nestle Healthcare Nutrition INC. | $165.36 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $150.15 | 2021-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $147.93 | 2021-2024 | |
| Phathom Pharmaceuticals, INC. | $141.29 | 2024 | Voquezna |
| Amarin Pharma, INC. | $132.00 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.